Çocuklarda henoch-schönlein purpurası: 50 olgunun retrospektif değerlendirilmesi

Amaç: Henoch-Schönlein purpurası başlıca çocukları etkileyen sistemik bir vaskülittir. Çalışmada Henoch-Schönlein purpurası tansı ile izlenen çocukları epidemiyolojik ve klinik özelliklerini değerlendirmeyi amaçladık. Gereç ve Yöntemler: Henoch-Schönlein purpurası tanısı alan tüm çocukların epidemiyolojik, klinik, laboratuar bulguları ve tedavi bilgileri dosya kayıtları incelenerek elde edildi. Bulgular: Yaşları 1.5 ile 16.5 arasında değişen 50 çocuk çalışmaya dahil edildi. Hastaların ortalama yaşları 7.9±3.6 yıl idi. Hastalarda en sık görülen bulgu purpura idi. Eklem tutulumu ve gastrointestinal tutulum hastalarda % 92 ve % 62 olarak belirlendi. Renal tutulum hastaların 10'nunda (% 20) meydana geldi. Bunların birinde şiddetli böbrek tutulumu oluştu. En sık görülen laboratuar anormalikleri lökositoz (%78), eritrosit sedimantasyon yüksekliği (% 48) ve IgA (% 26) yüksekliği idi. Sonuç: Hastaların epidemiyolojik ve klinik bulguları literatürdekilerle benzerlik gösteriyordu. Şiddetli böbrek tutulumu çocukların küçük bir kısmında olmasına rağmen, prognozu genellikle iyidir.

Henoch-schönlein purpura in the children: The evaluation retrospective of 50 patients

Objective: Henoch-Schönlein purpura is a systemic vasculitis which mainly affects the children. We aimed to evaluate the epidemiologic and clinical features of the children with diagnosis of Henoch-Schönlein Purpura followed up in our clinic. Materials and Methods: The epidemiological, clinical and laboratory findings, and the data about treatment of all patients with diagnosis of Henoch-Schönlein Purpura were collected by reviewing medical files. Results: 50 children (27 males, 23 females) aged between 1.5-16.5 years included in the study. The mean age of the patients was 7.9±3.6 years. Purpura was the most common finding seen in all patients. The joint involvement and gastrointestinal involvement occurred in 92 % and 62 % of these patients respectively. Renal involvement occurred in 10 patients (20 %), one of them had developed severe nephropathy. The most frequent laboratory abnormalities were leukocytosis (78 %), high erythrocyte sedimentation rate (48 %) and hyper IgA (26 %). Conclusion: Epidemiological and clinical findings of the patients are similar to those in the literature. Although severe nephropathy was found in a small percentage of the children, the prognosis was usually excellent.

___

  • 1) Cassidy JT, Petty RE. Leukocytoclastic vasculitis. In: Cassidy JT, Petty RE, editors. Textbook of pediatric Rheumatology. 5 th ed. W.B. Saunders Co. Philadelphia. 2005, p.496-501.
  • 2) Peru H, Soylemezoglu O, Bakkaloglu SA, et al. Henoch Schonlein purpura in chilhood: clinical analysis of 254 cases over a 3-year period. Clin Rheumatol 2008; 27: 1087-1092.
  • 3) Lahita RG. Influence of age on Henoch Schönlein purpura. Lancet 1997; 350:1116-1117.
  • 4) Szer IS. Henoch- Schönlein purpura: when and how to treat? J Rheumatol 1996; 23:1661-1665.
  • 5) Ronkainen J, Nuutinen M, Koskimies O. The adult kidney 24 years after childhood Henoch.Schönlein purpura: a retrospective cohort study. Lancet 2002; 360:666-700.
  • 6) Ronkainen J, Ala-Houhala M, Huttunen NP, et al. Outcome of Henoch.Schönlein nephritis with nephrotic-range proteinuria. Clin Nephrol 2003; 60:80-84.
  • 7) Goldstein AR, White RH, Akuse R, Chantler C. Long term followup of childhood Henoch.Schönlein nephritis. Lancet 1992; 339:280-282.
  • 8) Ozen S, Ruperto N, Dillon MJ, et al. EULAR/PReS Endorsed consensus criteria for the classification of childhood vasculites. Ann Rheum Dis 2006; 65: 936-941.
  • 9) Tizard EJ. Henoch-Schönlein purpura. Arch Dis Child 1999; 89: 380-383.
  • 10) İnal A, Yılmaz M, Kendirli SG, et al. Henoch-Schönlein purpurası tanısı olan çocukların klinik özellikleri. Erciyes Tıp Dergisi 2009; 31: 153-161.
  • 11) Saulsbury FT. Henoch Schönlein purpura in children: report of 100 patients and review of the literature. Medicine 1999; 78:395-409.
  • 12) Sano H, Izumida M, Shimizu H, Ogawa Y. Risk factors on renal involvement and significant proteinuria in Henoch Schönlein purpura. Eur J Pediatr 2002; 161:196-201.
  • 13) Calvino MC, Llorca J, Garcia-Porrua C, et al. Henoch Schönlein purpura in children from northwestern Spain: a 20-year epidemiologic and clinical study. Medicine 2001; 80:279-290.
  • 14) Abdel-Al YK, Hejazi Z, Majeed HA. Henoch Schönlein purpura in Arab children. Analysis of 52 cases. Trop Georg Med 1990; 42:52-57.
  • 15) Gardner-Medwin JM, Dolezalova P, Cummins C, Southwood TR. Incidence of Henoch Schönlein purpura, Kawasaki disease and rare vasculitides in children of different ethnic origins. Lancet 2002; 360:1197-1202.
  • 16) Dolezalova P, Telekesova P, Nemcova D, Hoza J. Incidence of vasculitis in children in the Czech republic: 2-year prospective epidemiology survey. J Rheumatol 2004; 31:2295-2299.
  • 17) Garcia-Porrua C, Calvino MC, Llorca J, Couselo JM, Gonzalez Gay MA. Henoch Schönlein purpura in children and adults: clinical differences in a defined population. Semin Arthritis Rheum 2002; 32:149-156.
  • 18) Trapani S, Micheli A, Grisolia F, et al. Henoch Schönlein purpura in childhood: epidemiological and clinical analysis of 150 cases over a 5-year period and review of literature. Semin Arthritis Rheum 2005; 35:143-153.
  • 19) Robson WL, Leung AK. Henoch Schönlein purpura. Adv Pediatr 1994; 41:163-194.
  • 20) Erdag GC, Vitrinel A, Yeşiltepe G, Gürsu DA, Ağzıkuru T, Akın Y. Henoch Schönlein Purpuralı 101 olgunun retrospektif değerlendirilmesi. Bakırköy Tıp Dergisi 2007; 3:10-14.
  • 21) Cull DL, Rosario V, Lally KP, Ratner I, Mahour GH. Surgical implications of Henoch.Schönlein purpura. J Pediatr Surg 1990;25:741-743.
  • 22) Martinez-Frontanilla LA, Silverman L, Meagher DP. Intussusception in Henoch.Schönlein purpura: diagnosis with ultrasound. J Pediatr Surg 1988; 23:375-376.
  • 23) Stewart M, Savage JM, Bell B, McCord B. Long term renal prognosis of Henoch.Schönlein purpura in an unselected childhood population. Eur J Pediatr 1988; 147:113-115.
  • 24) Mollica F, Li Volti S, Garozzo R, Russo G. Effectiveness of early prednisone treatment in preventing the development of nephropathy in anaphylactoid purpura. Eur J Pediatr 1992; 151:140-144.
  • 25) Scharer K, Krmar R, Querfeld U, Ruder H, Waldherr R, Schaefer F. Clinical outcome of Schönlein.Henoch purpura nephritis in children. Pediatr Nephrol 1999; 13:816-823.
  • 26) Kaku Y, Nohara K, Honda S. Renal involment in Henoch-Schönlein purpura: A multivariate anlysis of prognostic factors. Kidney Int 1998; 53: 1755-1759.
  • 27) Mills JA, Michel BA, Bloch DA, Calabrese LH, Hunder GG, Arend WP. The American College of Rheumatology 1990 criteria for the classification of Henoch Schönlein purpura. Arthritis Rheum 1990; 33:1114-1121.
  • 28) Coppo R, Amore A. Henoch-Schönlein Purpura. In: Avner ED, Harmon WE, Niaudet P, editors. Pediatric Nephrology, fifth edition. Lippincott Williams-Wilkins. Philadelphia. 2004, p.851-863.
Fırat Tıp Dergisi-Cover
  • ISSN: 1300-9818
  • Başlangıç: 2015
  • Yayıncı: Fırat Üniversitesi Tıp Fakültesi